Authors: Judson, I Radford, JA Harris, M Blay, JY van Hoesel, Q le Cesne, A van Oosterom, AT Clemons, MJ Kamby, C Hermans, C Whittaker, J di Paola, ED Verweij, J Nielsen, S

Citation: I. Judson et al., Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL (R)/CAELYX (R)) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group, EUR J CANC, 37(7), 2001, pp. 870-877

Authors: van Oosterom, AT Judson, I Verweij, J Stroobants, S di Paola, ED Dimitrijevic, S Martens, M Webb, A Sciot, R Van Glabbeke, M Silberman, S Nielsen, OS

Citation: At. Van Oosterom et al., Safety and efficacy of imatinib (ST1571) in metastatic gastrointestinal stromal tumours: a phase I study, LANCET, 358(9291), 2001, pp. 1421-1423

Authors: Verweij, J Lee, SM Ruka, W Buesa, J Coleman, R van Hoessel, R Seynaeve, C di Paola, ED van Glabbeke, M Tonelli, D Judson, IR

Citation: J. Verweij et al., Randomized phase II study of docetaxel versus doxorubicin in first- and second-line chemotherapy for locally advanced or metastatic soft tissue sarcomas in adults: A study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group, J CL ONCOL, 18(10), 2000, pp. 2081-2086